0001179110-18-014322.txt : 20181231
0001179110-18-014322.hdr.sgml : 20181231
20181231163728
ACCESSION NUMBER: 0001179110-18-014322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181227
FILED AS OF DATE: 20181231
DATE AS OF CHANGE: 20181231
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 181260126
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AxoGen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2018-12-27
0
0000805928
AxoGen, Inc.
AXGN
0001492710
Freitag Gregory Gene
13631 PROGRESS BLVD.
SUITE 400
ALACHUA
FL
32615
1
1
0
0
General Counsel
Employee Stock Option (right to purchase)
19.17
2018-12-27
4
A
0
18500
0
A
2028-12-27
Common Stock
18500
18500
D
Restricted Stock Units
2018-12-27
4
A
0
4600
0
A
Common Stock
4600
4600
D
All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock.
All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
/s/Gregory Freitag
2018-12-31